Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Cold-Spring-Harbor-Laboratory"

3 News Found

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
People | June 13, 2026

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor

Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders

Promising new universal coronavirus vaccine candidate discovered
News | May 05, 2022

Promising new universal coronavirus vaccine candidate discovered

Formula attenuates 99% of 365 coronaviruses in computer models

Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment
Biotech | April 08, 2022

Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment

Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting

Upcoming E-conference
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Dr. Manjiri Bakre CEO and Founder, OncoStem Diagnostics
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
Akhil Ravi Chief Executive Officer, Aurigene Pharmaceutical Services Limited

Packaging